Earnings call: Alimera Sciences reports robust Q1 2024 growth
Alimera Sciences (NASDAQ:ALIM) has reported a substantial increase in its first-quarter 2024 financial results, with consolidated global net revenue climbing 70% to $23 million from Q1 2023. This notable growth is largely attributed to the successful …